norbrook laboratories limited
norbrook laboratories limited Company Information
Company Number
NI007665
Website
www.norbrook.comRegistered Address
station works camlough road, newry, co. down, BT35 6JP
Industry
Manufacture of pharmaceutical preparations
Telephone
02830264435
Next Accounts Due
April 2025
Group Structure
View All
Shareholders
norbrook holdings ltd 100%
norbrook laboratories limited Estimated Valuation
The estimated valuation range for norbrook laboratories limited, derived from financial data as of July 2023 and the most recent industry multiples, is between £105.6m to £461.5m
norbrook laboratories limited Estimated Valuation
The estimated valuation range for norbrook laboratories limited, derived from financial data as of July 2023 and the most recent industry multiples, is between £105.6m to £461.5m
norbrook laboratories limited Estimated Valuation
The estimated valuation range for norbrook laboratories limited, derived from financial data as of July 2023 and the most recent industry multiples, is between £105.6m to £461.5m
Get a detailed valuation report, edit figures and unlock valuation multiples.
Norbrook Laboratories Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Norbrook Laboratories Limited Overview
Norbrook Laboratories Limited is a live company located in co. down, BT35 6JP with a Companies House number of NI007665. It operates in the manufacture of pharmaceutical preparations sector, SIC Code 21200. Founded in July 1969, it's largest shareholder is norbrook holdings ltd with a 100% stake. Norbrook Laboratories Limited is a mature, mega sized company, Pomanda has estimated its turnover at £198.5m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Norbrook Laboratories Limited Health Check
Pomanda's financial health check has awarded Norbrook Laboratories Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 3 areas for improvement. Company Health Check FAQs
6 Strong
3 Regular
3 Weak
Size
annual sales of £198.5m, make it larger than the average company (£26.8m)
£198.5m - Norbrook Laboratories Limited
£26.8m - Industry AVG
Growth
3 year (CAGR) sales growth of 6%, show it is growing at a faster rate (2.3%)
6% - Norbrook Laboratories Limited
2.3% - Industry AVG
Production
with a gross margin of 27.7%, this company has a comparable cost of product (32.9%)
27.7% - Norbrook Laboratories Limited
32.9% - Industry AVG
Profitability
an operating margin of 1.8% make it less profitable than the average company (5.2%)
1.8% - Norbrook Laboratories Limited
5.2% - Industry AVG
Employees
with 1569 employees, this is above the industry average (136)
1569 - Norbrook Laboratories Limited
136 - Industry AVG
Pay Structure
on an average salary of £43k, the company has a lower pay structure (£54.7k)
£43k - Norbrook Laboratories Limited
£54.7k - Industry AVG
Efficiency
resulting in sales per employee of £126.5k, this is less efficient (£243.7k)
£126.5k - Norbrook Laboratories Limited
£243.7k - Industry AVG
Debtor Days
it gets paid by customers after 18 days, this is earlier than average (57 days)
18 days - Norbrook Laboratories Limited
57 days - Industry AVG
Creditor Days
its suppliers are paid after 24 days, this is quicker than average (40 days)
24 days - Norbrook Laboratories Limited
40 days - Industry AVG
Stock Days
it holds stock equivalent to 107 days, this is in line with average (107 days)
107 days - Norbrook Laboratories Limited
107 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 8 weeks, this is average cash available to meet short term requirements (10 weeks)
8 weeks - Norbrook Laboratories Limited
10 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 27.1%, this is a lower level of debt than the average (45.7%)
27.1% - Norbrook Laboratories Limited
45.7% - Industry AVG
norbrook laboratories limited Credit Report and Business Information
Norbrook Laboratories Limited Competitor Analysis
Perform a competitor analysis for norbrook laboratories limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
norbrook laboratories limited Ownership
NORBROOK LABORATORIES LIMITED group structure
Norbrook Laboratories Limited has 4 subsidiary companies.
Ultimate parent company
1 parent
NORBROOK LABORATORIES LIMITED
NI007665
4 subsidiaries
norbrook laboratories limited directors
Norbrook Laboratories Limited currently has 11 directors. The longest serving directors include Professor The Honour James Haughey (Aug 2013) and Lady Mary Ballyedmond (Jun 2014).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Professor The Honour James Haughey | 43 years | Aug 2013 | - | Director | |
| Lady Mary Ballyedmond | 76 years | Jun 2014 | - | Director | |
| The Honourable Edward Haughey | United Kingdom | 44 years | Jun 2014 | - | Director |
| Mr Liam Nagle | Ireland | 61 years | Mar 2015 | - | Director |
| Sir Ian Gibson | 77 years | Jul 2016 | - | Director | |
| Mr Peter Johnston | Northern Ireland | 63 years | Mar 2020 | - | Director |
| Mr Kevin Kingston | England | 57 years | Mar 2022 | - | Director |
| The Honourable Caroline Braid | United Kingdom | 48 years | Mar 2022 | - | Director |
| Mr Shane Relihan | England | 48 years | Oct 2022 | - | Director |
| Mr Oliver McAllister | England | 48 years | May 2023 | - | Director |
NORBROOK LABORATORIES LIMITED financials
Norbrook Laboratories Limited's latest turnover from July 2023 is £198.5 million and the company has net assets of £129.1 million. According to their latest financial statements, Norbrook Laboratories Limited has 1,569 employees and maintains cash reserves of £6.9 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Aug 2019 | Aug 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Jul 2011 | Jul 2010 | Jul 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 198,512,000 | 190,227,000 | 195,649,000 | 167,657,000 | 188,410,000 | 228,695,000 | 223,502,000 | 206,216,000 | 202,241,000 | 183,214,000 | 188,456,000 | 180,657,720 | 160,888,858 | 135,908,083 | 121,718,712 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 143,565,000 | 126,677,000 | 132,133,000 | 121,817,000 | 148,524,000 | 150,693,000 | 138,227,000 | 133,145,000 | 127,546,000 | 114,809,000 | 116,376,000 | 112,278,337 | 98,065,375 | 84,299,274 | 76,286,732 |
| Gross Profit | 54,947,000 | 63,550,000 | 63,516,000 | 45,840,000 | 39,886,000 | 78,002,000 | 85,275,000 | 73,071,000 | 74,695,000 | 68,405,000 | 72,080,000 | 68,379,383 | 62,823,483 | 51,608,809 | 45,431,980 |
| Admin Expenses | 51,290,000 | 48,225,000 | 45,700,000 | 45,939,000 | 44,226,000 | 51,627,000 | 43,878,000 | 36,758,000 | 39,880,000 | 50,911,000 | 54,996,000 | 50,505,638 | 43,871,954 | 39,254,293 | 36,427,899 |
| Operating Profit | 3,657,000 | 15,325,000 | 17,816,000 | -99,000 | -4,340,000 | 26,375,000 | 41,397,000 | 36,313,000 | 34,815,000 | 17,494,000 | 17,084,000 | 17,873,745 | 18,951,529 | 12,354,516 | 9,004,081 |
| Interest Payable | 1,627,000 | 925,000 | 1,209,000 | 1,447,000 | 4,501,000 | 1,702,000 | 1,594,000 | 1,232,000 | 1,975,000 | 2,992,000 | 2,982,000 | 2,577,830 | 2,383,359 | 2,710,238 | 3,707,835 |
| Interest Receivable | 0 | 2,015,000 | 32,000 | 819,000 | 1,113,000 | 0 | 0 | 0 | 12,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pre-Tax Profit | 2,030,000 | 26,930,000 | 16,639,000 | 2,900,000 | -7,728,000 | 38,031,000 | 39,669,000 | 62,814,000 | 23,170,000 | 17,599,000 | 14,401,000 | 15,874,578 | 16,775,827 | 10,358,572 | 4,376,006 |
| Tax | -230,000 | -1,993,000 | -2,631,000 | 7,000 | 1,846,000 | -3,717,000 | -6,774,000 | -5,758,000 | -4,463,000 | -3,467,000 | -2,919,000 | -3,797,074 | -3,599,660 | -3,035,773 | -1,353,207 |
| Profit After Tax | 1,800,000 | 24,937,000 | 14,008,000 | 2,907,000 | -5,882,000 | 34,314,000 | 32,895,000 | 57,056,000 | 18,707,000 | 14,132,000 | 11,482,000 | 12,077,504 | 13,176,167 | 7,322,799 | 3,022,799 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 13,665,000 | 15,000,000 | 0 | 0 | 0 | 0 | 2,500,000 | 0 | 0 | 0 |
| Retained Profit | 1,800,000 | 24,937,000 | 14,008,000 | 2,907,000 | -5,882,000 | 20,649,000 | 17,895,000 | 57,056,000 | 18,707,000 | 14,132,000 | 11,482,000 | 9,577,504 | 13,176,167 | 7,322,799 | 3,022,799 |
| Employee Costs | 67,462,000 | 63,475,000 | 59,260,000 | 57,946,000 | 57,394,000 | 63,978,000 | 57,360,000 | 58,971,000 | 51,442,000 | 56,139,000 | 52,345,000 | 48,595,605 | 40,243,257 | 35,583,040 | 31,482,058 |
| Number Of Employees | 1,569 | 1,488 | 1,459 | 1,497 | 1,577 | 1,614 | 1,697 | 1,798 | 1,710 | 1,791 | 1,673 | 1,533 | 1,424 | 1,293 | 1,138 |
| EBITDA* | 10,279,000 | 21,433,000 | 23,360,000 | 5,575,000 | 2,950,000 | 33,839,000 | 46,493,000 | 41,007,000 | 37,174,000 | 23,730,000 | 23,291,000 | 22,545,259 | 23,404,406 | 16,631,838 | 13,461,108 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Aug 2019 | Aug 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Jul 2011 | Jul 2010 | Jul 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 85,641,000 | 86,863,000 | 78,726,000 | 73,229,000 | 70,976,000 | 66,483,000 | 61,223,000 | 51,412,000 | 64,704,000 | 72,296,000 | 80,486,000 | 71,580,534 | 63,378,490 | 58,999,431 | 58,494,334 |
| Intangible Assets | 398,000 | 366,000 | 180,000 | 0 | 46,000 | 115,000 | 184,000 | 253,000 | 323,000 | 960,000 | 500,000 | 569,680 | 649,935 | 719,643 | 232,074 |
| Investments & Other | 3,665,000 | 3,665,000 | 3,675,000 | 4,075,000 | 4,075,000 | 4,179,000 | 1,683,000 | 1,683,000 | 25,323,000 | 37,813,000 | 35,952,000 | 34,333,979 | 31,727,950 | 23,325,758 | 21,904,537 |
| Debtors (Due After 1 year) | 2,853,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10,527,182 | 11,278,678 | 0 |
| Total Fixed Assets | 92,557,000 | 90,894,000 | 82,581,000 | 77,304,000 | 75,097,000 | 70,777,000 | 63,090,000 | 53,348,000 | 90,350,000 | 111,069,000 | 116,938,000 | 106,484,193 | 106,283,557 | 94,323,510 | 80,630,945 |
| Stock & work in progress | 42,215,000 | 41,175,000 | 36,265,000 | 37,340,000 | 37,174,000 | 37,183,000 | 32,761,000 | 34,405,000 | 31,161,000 | 35,900,000 | 35,186,000 | 27,508,277 | 26,445,331 | 23,610,858 | 17,359,851 |
| Trade Debtors | 9,830,000 | 11,076,000 | 16,159,000 | 12,153,000 | 17,012,000 | 19,526,000 | 19,376,000 | 18,243,000 | 20,244,000 | 41,877,000 | 52,877,000 | 44,607,006 | 37,726,136 | 38,956,556 | 46,474,324 |
| Group Debtors | 19,322,000 | 20,110,000 | 20,745,000 | 20,785,000 | 17,013,000 | 29,846,000 | 29,950,000 | 34,380,000 | 46,051,000 | 22,915,000 | 15,347,000 | 15,403,874 | 592,346 | 0 | 14,842,070 |
| Misc Debtors | 6,226,000 | 8,913,000 | 12,969,000 | 10,423,000 | 7,956,000 | 5,623,000 | 2,762,000 | 8,573,000 | 7,373,000 | 8,309,000 | 6,749,000 | 5,020,731 | 4,862,324 | 2,863,477 | 1,920,609 |
| Cash | 6,935,000 | 24,639,000 | 9,057,000 | 562,000 | 0 | 8,462,000 | 18,200,000 | 166,000 | 4,047,000 | 10,361,000 | 2,466,000 | 69,290 | 728,316 | 307,750 | 1,789,995 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 84,528,000 | 105,913,000 | 95,195,000 | 81,263,000 | 79,155,000 | 100,640,000 | 103,049,000 | 95,767,000 | 108,876,000 | 119,362,000 | 112,625,000 | 92,609,178 | 70,354,453 | 65,738,641 | 82,386,849 |
| total assets | 177,085,000 | 196,807,000 | 177,776,000 | 158,567,000 | 154,252,000 | 171,417,000 | 166,139,000 | 149,115,000 | 199,226,000 | 230,431,000 | 229,563,000 | 199,093,371 | 176,638,010 | 160,062,151 | 163,017,794 |
| Bank overdraft | 0 | 0 | 0 | 0 | 2,437,000 | 0 | 4,967,000 | 11,360,000 | 14,897,000 | 51,319,000 | 42,098,000 | 37,708,208 | 38,331,462 | 34,401,676 | 39,023,081 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 15,466,000 | 1,196,000 | 2,072,000 | 1,798,000 | 2,393,000 | 9,854,684 | 11,307,893 | 14,390,614 | 2,621,181 |
| Trade Creditors | 9,573,000 | 10,203,000 | 10,017,000 | 11,226,000 | 6,596,000 | 11,572,000 | 7,910,000 | 7,092,000 | 12,494,000 | 14,110,000 | 25,124,000 | 23,128,737 | 18,547,810 | 16,559,406 | 15,958,968 |
| Group/Directors Accounts | 18,516,000 | 25,035,000 | 18,623,000 | 19,579,000 | 18,778,000 | 25,393,000 | 30,399,000 | 23,667,000 | 48,722,000 | 3,178,000 | 2,964,000 | 2,551,237 | 2,371,616 | 2,413,613 | 5,857,910 |
| other short term finances | 1,655,000 | 5,501,000 | 543,000 | 0 | 6,698,000 | 1,425,000 | 552,000 | 4,087,000 | 5,000 | 196,000 | 190,000 | 5,000 | 283,598 | 263,675 | 245,000 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 208,000 | 1,064,000 | 1,182,000 | 1,392,000 | 1,493,000 | 1,469,402 | 1,173,919 | 1,070,548 | 894,616 |
| other current liabilities | 11,366,000 | 18,333,000 | 17,647,000 | 15,104,000 | 16,807,000 | 20,335,000 | 16,950,000 | 14,082,000 | 16,490,000 | 22,655,000 | 22,198,000 | 20,879,112 | 16,961,391 | 15,849,399 | 13,004,702 |
| total current liabilities | 41,110,000 | 59,072,000 | 46,830,000 | 45,909,000 | 51,316,000 | 58,725,000 | 76,452,000 | 62,548,000 | 95,862,000 | 94,648,000 | 96,460,000 | 95,596,380 | 88,977,689 | 84,948,931 | 77,605,458 |
| loans | 0 | 4,105,000 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | 27,806,000 | 17,024,000 | 33,181,000 | 43,503,000 | 23,857,890 | 18,092,074 | 19,409,105 | 36,767,132 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 274,000 | 1,317,000 | 1,251,000 | 500,000 | 833,383 | 304,550 | 266,576 | 135,570 |
| Accruals and Deferred Income | 387,000 | 505,000 | 672,000 | 838,000 | 0 | 1,172,000 | 2,381,000 | 2,557,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 6,468,000 | 4,155,000 | 5,406,000 | 2,039,000 | 165,000 | 2,285,000 | 1,690,000 | 1,099,000 | 1,140,000 | 341,000 | 1,114,000 | 2,361,545 | 2,091,414 | 2,739,440 | 2,788,449 |
| total long term liabilities | 6,855,000 | 8,765,000 | 16,078,000 | 12,877,000 | 10,165,000 | 13,457,000 | 14,071,000 | 31,736,000 | 19,481,000 | 34,773,000 | 45,117,000 | 27,052,818 | 20,488,038 | 22,415,121 | 39,691,151 |
| total liabilities | 47,965,000 | 67,837,000 | 62,908,000 | 58,786,000 | 61,481,000 | 72,182,000 | 90,523,000 | 94,284,000 | 115,343,000 | 129,421,000 | 141,577,000 | 122,649,198 | 109,465,727 | 107,364,052 | 117,296,609 |
| net assets | 129,120,000 | 128,970,000 | 114,868,000 | 99,781,000 | 92,771,000 | 99,235,000 | 75,616,000 | 54,831,000 | 83,883,000 | 101,010,000 | 87,986,000 | 76,444,173 | 67,172,283 | 52,698,099 | 45,721,185 |
| total shareholders funds | 129,120,000 | 128,970,000 | 114,868,000 | 99,781,000 | 92,771,000 | 99,235,000 | 75,616,000 | 54,831,000 | 83,883,000 | 101,010,000 | 87,986,000 | 76,444,173 | 67,172,283 | 52,698,099 | 45,721,185 |
| Jul 2023 | Jul 2022 | Jul 2021 | Jul 2020 | Aug 2019 | Aug 2018 | Jul 2017 | Jul 2016 | Jul 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Jul 2011 | Jul 2010 | Jul 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 3,657,000 | 15,325,000 | 17,816,000 | -99,000 | -4,340,000 | 26,375,000 | 41,397,000 | 36,313,000 | 34,815,000 | 17,494,000 | 17,084,000 | 17,873,745 | 18,951,529 | 12,354,516 | 9,004,081 |
| Depreciation | 6,622,000 | 6,108,000 | 5,544,000 | 5,628,000 | 7,221,000 | 7,395,000 | 5,027,000 | 4,624,000 | 2,291,000 | 6,149,000 | 6,134,000 | 4,598,211 | 4,379,399 | 4,216,568 | 4,416,134 |
| Amortisation | 0 | 0 | 0 | 46,000 | 69,000 | 69,000 | 69,000 | 70,000 | 68,000 | 87,000 | 73,000 | 73,303 | 73,478 | 60,754 | 40,893 |
| Tax | -230,000 | -1,993,000 | -2,631,000 | 7,000 | 1,846,000 | -3,717,000 | -6,774,000 | -5,758,000 | -4,463,000 | -3,467,000 | -2,919,000 | -3,797,074 | -3,599,660 | -3,035,773 | -1,353,207 |
| Stock | 1,040,000 | 4,910,000 | -1,075,000 | 166,000 | -9,000 | 4,422,000 | -1,644,000 | 3,244,000 | -4,739,000 | 714,000 | 7,677,723 | 1,062,946 | 2,834,473 | 6,251,007 | 17,359,851 |
| Debtors | -1,868,000 | -9,774,000 | 6,512,000 | 1,380,000 | -13,014,000 | 2,907,000 | -9,108,000 | -12,472,000 | 567,000 | -1,872,000 | 9,941,389 | 11,323,623 | 609,277 | -10,138,292 | 63,237,003 |
| Creditors | -630,000 | 186,000 | -1,209,000 | 4,630,000 | -4,976,000 | 3,662,000 | 818,000 | -5,402,000 | -1,616,000 | -11,014,000 | 1,995,263 | 4,580,927 | 1,988,404 | 600,438 | 15,958,968 |
| Accruals and Deferred Income | -7,085,000 | 519,000 | 2,377,000 | -865,000 | -4,700,000 | 2,176,000 | 2,692,000 | 149,000 | -6,165,000 | 457,000 | 1,318,888 | 3,917,721 | 1,111,992 | 2,844,697 | 13,004,702 |
| Deferred Taxes & Provisions | 2,313,000 | -1,251,000 | 3,367,000 | 1,874,000 | -2,120,000 | 595,000 | 591,000 | -41,000 | 799,000 | -773,000 | -1,247,545 | 270,131 | -648,026 | -49,009 | 2,788,449 |
| Cash flow from operations | 5,475,000 | 23,758,000 | 19,827,000 | 9,675,000 | 6,023,000 | 29,226,000 | 54,572,000 | 39,183,000 | 29,901,000 | 10,091,000 | 4,819,494 | 15,130,395 | 18,813,366 | 20,879,476 | -36,736,834 |
| Investing Activities | |||||||||||||||
| capital expenditure | 4,600,000 | -12,729,000 | -12,959,529 | -14,475,020 | -5,150,477 | -3,600,758 | |||||||||
| Change in Investments | 0 | -10,000 | -400,000 | 0 | -104,000 | 2,496,000 | 0 | -23,640,000 | -12,490,000 | 1,861,000 | 1,618,021 | 2,606,029 | 8,402,192 | 1,421,221 | 21,904,537 |
| cash flow from investments | 2,739,000 | -14,347,021 | -15,565,558 | -22,877,212 | -6,571,698 | -25,505,295 | |||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | -15,466,000 | 14,270,000 | -876,000 | 274,000 | -595,000 | -7,461,684 | -1,453,209 | -3,082,721 | 11,769,433 | 2,621,181 |
| Group/Directors Accounts | -6,519,000 | 6,412,000 | -956,000 | 801,000 | -6,615,000 | -5,006,000 | 6,732,000 | -25,055,000 | 45,544,000 | 214,000 | 412,763 | 179,621 | -41,997 | -3,444,297 | 5,857,910 |
| Other Short Term Loans | -3,846,000 | 4,958,000 | 543,000 | -6,698,000 | 5,273,000 | 873,000 | -3,535,000 | 4,082,000 | -191,000 | 6,000 | 185,000 | -278,598 | 19,923 | 18,675 | 245,000 |
| Long term loans | -4,105,000 | -5,895,000 | 0 | 0 | 0 | 0 | -17,806,000 | 10,782,000 | -16,157,000 | -10,322,000 | 19,645,110 | 5,765,816 | -1,317,031 | -17,358,027 | 36,767,132 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | -208,000 | -1,130,000 | -1,161,000 | -144,000 | 650,000 | -309,785 | 824,316 | 141,345 | 306,938 | 1,030,186 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||||||
| interest | -1,627,000 | 1,090,000 | -1,177,000 | -628,000 | -3,388,000 | -1,702,000 | -1,594,000 | -1,232,000 | -1,963,000 | -2,992,000 | -2,982,000 | -2,577,830 | -2,383,359 | -2,710,238 | -3,707,835 |
| cash flow from financing | -17,747,000 | -4,270,000 | -511,000 | -2,422,000 | -5,312,000 | -18,539,000 | -173,000 | -99,568,000 | -8,471,000 | -14,147,000 | 9,549,231 | 2,154,502 | -5,365,823 | -11,763,401 | 85,511,960 |
| cash and cash equivalents | |||||||||||||||
| cash | -17,704,000 | 15,582,000 | 8,495,000 | 562,000 | -8,462,000 | -9,738,000 | 18,034,000 | -3,881,000 | -6,314,000 | 7,895,000 | 2,396,710 | -659,026 | 420,566 | -1,482,245 | 1,789,995 |
| overdraft | 0 | 0 | 0 | -2,437,000 | 2,437,000 | -4,967,000 | -6,393,000 | -3,537,000 | -36,422,000 | 9,221,000 | 4,389,792 | -623,254 | 3,929,786 | -4,621,405 | 39,023,081 |
| change in cash | -17,704,000 | 15,582,000 | 8,495,000 | 2,999,000 | -10,899,000 | -4,771,000 | 24,427,000 | -344,000 | 30,108,000 | -1,326,000 | -1,993,082 | -35,772 | -3,509,220 | 3,139,160 | -37,233,086 |
P&L
July 2023turnover
198.5m
+4%
operating profit
3.7m
-76%
gross margin
27.7%
-17.15%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
July 2023net assets
129.1m
0%
total assets
177.1m
-0.1%
cash
6.9m
-0.72%
net assets
Total assets minus all liabilities
Similar Companies
norbrook laboratories limited company details
company number
NI007665
Type
Private limited with Share Capital
industry
21200 - Manufacture of pharmaceutical preparations
incorporation date
July 1969
age
55
accounts
Full Accounts
ultimate parent company
previous names
N/A
incorporated
UK
address
station works camlough road, newry, co. down, BT35 6JP
last accounts submitted
July 2023
norbrook laboratories limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 47 charges/mortgages relating to norbrook laboratories limited. Currently there are 5 open charges and 42 have been satisfied in the past.
norbrook laboratories limited Companies House Filings - See Documents
| date | description | view/download |
|---|
